Seizure activity involved in the up-regulation of BDNF mRNA expression by activation of central Mu opioid receptors

Neuroscience

Volumn 161, Issue 1, 2009, Pages 301-310

  Zhang, H N ^a   Ko, M C ^b,c  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c Department of Psychology   (Taiwan)

Author keywords

behavioral seizures; frontal cortex; hippocampus; in situ hybridization; neurotrophins; opioids

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; DIAZEPAM; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; MESSENGER RNA; MORPHINE; MU OPIATE RECEPTOR; NALOXONE; PHENOBARBITAL; VALPROIC ACID;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DRUG EFFECT; ENZYME ACTIVATION; ENZYME REGULATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SEIZURE;

ANIMALS; ANTICONVULSANTS; BRAIN-DERIVED NEUROTROPHIC FACTOR; DRUG SYNERGISM; ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-; INJECTIONS, INTRAVENTRICULAR; MALE; MORPHINE; NALOXONE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID, MU; RNA, MESSENGER; SEIZURES; UP-REGULATION;

EID: 67349267815     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2009.03.020     Document Type: Article

References (48)

1. Adler M.W., Rowan C.H., and Geller E.B. Intracerebroventricular vs. subcutaneous drug administration: apples and oranges?. Neuropeptides 5 (1984) 73-76
2. Berman E.F., and Adler M.W. The anticonvulsant effect of opioids and opioid peptides against maximal electroshock seizures in rats. Neuropharmacology 23 (1984) 367-371
3. Binder D.K. The role of BDNF in epilepsy and other diseases of the mature nervous system. Adv Exp Med Biol 548 (2004) 34-56
4. Broom D.C., Jutkiewicz E.M., Folk J.E., Traynor J.R., Rice K.C., and Woods J.H. Nonpeptidic delta-opioid receptor agonists reduce immobility in the forced swim assay in rats. Neuropsychopharmacology 26 (2002) 744-755
5. Conti B., Maier R., Barr A.M., Morale M.C., Lu X., Sanna P.P., Bilbe G., Hoyer D., and Bartfai T. Region-specific transcriptional changes following the three antidepressant treatments electro convulsive therapy, sleep deprivation and fluoxetine. Mol Psychiatry 12 (2007) 167-189
6. Dias B.G., Banerjee S.B., Duman R.S., and Vaidya V.A. Differential regulation of brain derived neurotrophic factor transcripts by antidepressant treatments in the adult rat brain. Neuropharmacology 45 (2003) 553-563
7. Dugich-Djordjevic M.M., Tocco G., Lapchak P.A., Pasinetti G.M., Najm I., Baudry M., and Hefti F. Regionally specific and rapid increases in brain-derived neurotrophic factor messenger RNA in the adult rat brain following seizures induced by systemic administration of kainic acid. Neuroscience 47 (1992) 303-315
8. Duman R.S., and Monteggia L.M. A neurotrophic model for stress-related mood disorders. Biol Psychiatry 59 (2006) 1116-1127
9. Ernfors P., Bengzon J., Kokaia Z., Persson H., and Lindvall O. Increased levels of messenger RNAs for neurotrophic factors in the brain during kindling epileptogenesis. Neuron 7 (1991) 165-176
10. Fraser G.L., Gaudreau G.A., Clarke P.B.S., Menard D.P., and Perkins M.N. Antihyperalgesic effects of δ opioid agonists in a rat model of chronic inflammation. Br J Pharmacol 129 (2000) 1668-1672
11. French S.J., Humby T., Horner C.H., Sofroniew M.V., and Rattray M. Hippocampal neurotrophin and trk receptor mRNA levels are altered by local administration of nicotine, carbachol and pilocarpine. Mol Brain Res 67 (1999) 124-136
12. Frenk H. Pro- and anticonvulsant actions of morphine and the endogenous opioids: involvement and interactions of multiple opiate and non-opiate systems. Brain Res 287 (1983) 197-210
13. Gogas K.R., Cho H.J., Botchkina G.I., Levine J.D., and Basbaum A.I. Inhibition of noxious stimulus-evoked pain behaviors and neuronal fos-like immunoreactivity in the spinal cord of the rat by supraspinal morphine. Pain 65 (1996) 9-15
14. Golarai G., Cavazos J.E., and Sutula T.P. Activation of the dentate gyrus by pentylenetetrazol evoked seizures induces mossy fiber synaptic reorganization. Brain Res 593 (1992) 257-264
15. Groudine S.B., Cresanti-Daknis C., and Lumb P.D. Successful treatment of a massive intrathecal morphine overdose. Anesthesiology 82 (1995) 292-295
16. Heese K., Otten U., Mathivet P., Raiteri, Marescaux C., and Bernasconi R. GABAB receptor antagonists elevate both mRNA and protein levels of the neurotrophins nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF) but not neurotrophin-3 (NT-3) in brain and spinal cord of rats. Neuropharmacology 39 (2000) 449-462
17. Humpel C., Wetmore C., and Olson L. Regulation of brain-derived neurotrophic factor messenger RNA and protein at the cellular level in pentylenetetrazol-induced epileptic seizures. Neuroscience 53 (1993) 909-918
18. Isackson P.J., Huntsman M.M., Murray K.D., and Gall C.M. BDNF mRNA expression is increased in adult rat forebrain after limbic seizures: temporal patterns of induction distinct from NGF. Neuron 6 (1991) 937-948
19. Keith D.E., Murray S.R., Zaki P.A., Chu P.C., Lissin D.V., Kang L., Evans C.J., and von Zastrow M. Morphine activates opioid receptors without causing their rapid internalization. J Biol Chem 271 (1996) 19021-19024
20. Koyama R., and Ikegaya Y. To BDNF or not to BDNF: that is the epileptic hippocampus. Neuroscientist 11 (2005) 282-287
21. Kulkarni S.K., and Nagrath A. Modification by GABA-ergic agents and clonidine of morphine- induced convulsions and toxicity in rats. Clin Exp Pharmacol Physiol 10 (1983) 125-129
22. Liao D., Grigoriants O.O., Wang W., Wiens K., Loh H.H., and Law P.Y. Distinct effects of individual opioids on the morphology of spines depend upon the internalization of mu opioid receptors. Mol Cell Neurosci 35 (2007) 456-469
23. Marmigère F., Rage F., and Tapia-Arancibia L. GABA-glutamate interaction in the control of BDNF expression in hypothalamic neurons. Neurochem Int 42 (2003) 353-358
24. Martinowich K., Manji H., and Lu B. New insights into BDNF function in depression and anxiety. Nat Neurosci 10 (2007) 1089-1093
25. McQuiston A.R., and Saggau P. Mu-opioid receptors facilitate the propagation of excitatory activity in rat hippocampal area CA1 by disinhibition of all anatomical layers. J Neurophysiol 90 (2003) 1936-1348
26. Metsis M., Timmusk T., Arenas E., and Persson H. Differential usage of multiple brain-derived neurotrophic factor promoters in the rat brain following neuronal activation. Proc Natl Acad Sci U S A 90 (1993) 8802-8806
27. Owens M.J., and Nemeroff C.B. Pharmacology of valproate. Psychopharmacol Bull 37 Suppl 2 (2003) 17-24
28. Paxinos G., and Watson C. The rat brain in stereotaxic coordinates. 2nd ed. (1986), Academic Press, San Diego, CA
29. Pezet S., and Malcangio M. Brain-derived neurotrophic factor as a drug target for CNS disorders. Expert Opin Ther Targets 8 (2004) 391-399
30. 2+ entry. Neuroscience 126 (2004) 665-676
31. Rocamora N., Palacios J.M., and Mengod G. Limbic seizures induce a differential regulation of the expression of nerve growth factor, brain-derived neurotrophic factor and neurotrophin-3, in the rat hippocampus. Brain Res Mol Brain Res 13 (1992) 27-33
32. Rodriguez-Munoz M., de la Torre-Madrid E., Sanchez-Blazquez P., and Garzon J. Morphine induces endocytosis of neuronal mu-opioid receptors through the sustained transfer of Galpha subunits to RGSZ2 proteins. Mol Pain 3 (2007) 19
33. Saidak Z., Blake-Palmer K., Hay D.L., Northup J.K., and Glass M. Differential activation of G- proteins by mu-opioid receptor agonists. Br J Pharmacol 147 (2006) 671-680
34. Sauter K., Kaufman H.H., Bloomfield S.M., Cline S., and Banks D. Treatment of high-dose intrathecal morphine overdose. Case report. J Neurosurg 81 (1994) 143-146
35. Snead III O.C., and Bearden L.J. Anticonvulsants specific for petit mal antagonize epileptogenic effect of leucine enkephalin. Science 210 (1980) 1031-1033
36. Snead III O.C., and Bearden L.J. The epileptogenic spectrum of opiate agonists. Neuropharmacology 21 (1982) 1137-1144
37. Suarez-Roca H., and Maixner W. Morphine produces a multiphasic effect on the release of substance P from rat trigeminal nucleus slices by activating different opioid receptor subtypes. Brain Res 579 (1992) 195-203
38. Takayama N., and Ueda H. Morphine-induced chemotaxis and brain-derived neurotrophic factor expression in microglia. J Neurol Sci 25 (2005) 430-435
39. Torregrossa M.M., Isgor C., Folk J.E., Rice K.C., Watson S.J., and Woods J.H. The delta-opioid receptor agonist (+)BW373U86 regulates BDNF mRNA expression in rats. Neuropsychopharmacology 29 (2004) 649-659
40. Tortella F.C., Moreton J.E., and Khazan N. Electroencephalographic and behavioral effects of D- ala2-methionine-enkephalinamide and morphine in the rat. J Pharmacol Exp Ther 206 (1978) 636-643
41. Tortella F.C., Robles L., and Mosberg H.I. Evidence for mu opioid receptor mediation of enkephalin-induced electroencephalographic seizures. J Pharmacol Exp Ther 240 (1987) 571-577
42. Urca G., and Frenk H. Systemic morphine blocks the seizures induced by intracerebroventricular (i.c.v.) injections of opiates and opioid peptides. Brain Res 246 (1982) 121-126
43. Urca G., Frenk H., Liebeskind J.C., and Taylor A.N. Morphine and enkephalin: analgesic and epileptic properties. Science 197 (1977) 83-86
44. Vissers K.C.P., Greenen F., Biermans R., and Meert T.F. Pharmacological correlation between the Formalin test and the neuropathic pain behavior in different species with chronic constriction injury. Pharmacol Biochem Behav 84 (2006) 479-486
45. Walker E.A., Makhay M.M., House J.D., and Young A.M. In vivo apparent pA2 analysis for naltrexone antagonism of discriminative stimulus and analgesic effects of opiate agonists in rats. J Pharmacol Exp Ther 271 (1994) 959-968
46. Zafra F., Castrén E., Thoenen H., and Lindholm D. Interplay between glutamate and gamma- aminobutyric acid transmitter systems in the physiological regulation of brain-derived neurotrophic factor and nerve growth factor synthesis in hippocampal neurons. Proc Natl Acad Sci U S A 88 (1991) 10037-10041
47. Zhang H., Torregrossa M.M., Jutkiewicz E.M., Shi Y.G., Rice K.C., Woods J.H., Watson S.J., and Ko M.C.H. Endogenous opioids upregulate brain-derived neurotrophic factor mRNA through delta- and mu-opioid receptors independent of antidepressant-like effects. Eur J Neurosci 23 (2006) 984-994
48. Zuccato C., and Cattaneo E. Role of brain-derived neurotrophic factor in Huntington's disease. Prog Neurobiol 81 (2007) 294-330